Ingestible Smart Pills Market 2022-2028

Description

List of Tables

Title:Global Ingestible Smart Pills Market Size, Share, and Trends Analysis Report, by Component (Smart Pills (Patient Monitoring and Capsule Endoscopy (Small Bowel Endoscopy, Esophagus Endoscopy, and Colon Endoscopy)) and Workstation), Application (Imaging and Monitoring), and By End-User (Hospital, Clinics, Research Institutes, and Homecare), Forecast Period (2022-2028).

The global ingestible smart pills market is anticipated to grow at a CAGR of 6.2% during the forecast period. The emerging application of ingestible smart pills in sports, astronauts, animal care, mining, fire fighting, and the military for the monitoring of core body temperature as compared with the external temperature of the working environment is generating new opportunities for the growth of the ingestible smart pills market. Abilify MyCite is the first pill approved by the USFDA for medication monitoring which is used by physicians on patients suffering from mental disorders. This report will further analyze all the primary as well as secondary factors that are directly or indirectly impacting the growth of the market.

The global ingestible smart pills market is segmented based on the component, application, and end-user. Based on the component, the market is segmented into smart pills and workstations. The smart pills segment is further segmented as patient monitoring and capsule endoscopy. The capsule endoscopy includes small bowel endoscopy, esophagus endoscopy, and colon endoscopy. Based on the application, the market is sub-segmented into imaging and monitoring. Based on the end-user, the market is sub-segmented as hospitals, clinics, research institutes, and homecare. The above-mentioned segments can also be customized as per the requirements.

Geographically, the global ingestible smart pills market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The market can also be analyzed for a particular region or country level as per the requirement. The technological advancement and increasing adoption of IoT in the North American region had taken them one step ahead in the ingestible smart pills market through the developments, such as advanced wireless minimally invasive capsule endoscopy. The Asia Pacific region is expected to be the fastest-growing region in the ingestible smart pills market owing to its huge population and increasing chronic diseases. Japan, China, and India are the major contributing nations in this regional market.

The major companies serving the global ingestible smart pills market include GE Healthcare, Siemens AG, Novartis International AG, Boston Scientific Corp., Medimetrics, IntroMedic Co., Ltd., Philips Healthcare, and Medtronic plc, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, CapsoVision, Inc. and PENTAX Medical partnered in June 2018 to sell CapsoCam Plus which offers 360° lateral imaging with four cameras.

Research Methodology

The market study of the global ingestible smart pills market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Ingestible Smart Pills Market Research and Analysis by Component.
Global Ingestible Smart Pills Market Research and Analysis by Application.
Global Ingestible Smart Pills Market Research and Analysis by End-User.

The Report Covers:

Comprehensive research methodology of the global ingestible smart pills market.
This report also includes a detailed and extensive market overview with key analyst insights.
An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global ingestible smart pills market.
Insights about market determinants that are stimulating the global ingestible smart pills market.
Detailed and extensive market segments with the regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

Product Code: OMR2026721

1. Report Summary

1.1. Research Methods and Tools
1.2. Market Breakdown
- 1.2.1. By Segments
- 1.2.2. By Region

2. Market Overview and Insights

2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Findings
- 2.2.2. Recommendations
- 2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis
- 3.1.1. GE Healthcare
  - 3.1.1.1. Overview
  - 3.1.1.2. Financial Analysis
  - 3.1.1.3. SWOT Analysis
  - 3.1.1.4. Recent Developments
- 3.1.2. Siemens AG
  - 3.1.2.1. Overview
  - 3.1.2.2. Financial Analysis
  - 3.1.2.3. SWOT Analysis
  - 3.1.2.4. Recent Developments
- 3.1.3. Novartis International AG
  - 3.1.3.1. Overview
  - 3.1.3.2. Financial Analysis
  - 3.1.3.3. SWOT Analysis
  - 3.1.3.4. Recent Developments
3.2. Key Strategy Analysis

4. Market Segmentation

4.1. Global Ingestible Smart Pills Market by Component
- 4.1.1. Smart Pills
  - 4.1.1.1. Patient Monitoring
  - 4.1.1.2. Capsule Endoscopy
    - 4.1.1.2.1. Small Bowel Endoscopy
    - 4.1.1.2.2. Esophagus Endoscopy
    - 4.1.1.2.3. Colon Endoscopy
- 4.1.2. Workstation
4.2. Global Ingestible Smart Pills Market by Application
- 4.2.1. Imaging
- 4.2.2. Monitoring
4.3. Global Ingestible Smart Pills Market by End-User
- 4.3.1. Hospitals
- 4.3.2. Clinics
- 4.3.3. Research Institutes
- 4.3.4. Homecare

5. Regional Analysis

5.1. North America
- 5.1.1. US
- 5.1.2. Canada
5.2. Europe
- 5.2.1. UK
- 5.2.2. Germany
- 5.2.3. Italy
- 5.2.4. Spain
- 5.2.5. France
- 5.2.6. Rest of Europe
5.3. Asia-Pacific
- 5.3.1. China
- 5.3.2. India
- 5.3.3. Japan
- 5.3.4. Rest of Asia-Pacific
5.4. Rest of the World

6. Company Profiles

6.1. BodyCap Medical
6.2. Boston Scientific Corp.
6.3. CapsoVision, Inc.
6.4. Check-Cap Ltd.
6.5. Chongqing Jinshan Science and Component (Group) Co., Ltd.
6.6. etectRx, Inc.
6.7. Given Imaging Ltd.
6.8. HQ Inc.
6.9. Medimetrics, IntroMedic Co., Ltd.
6.10. Medtronic plc
6.11. Olympus Corp.
6.12. Pentax Medical Co. (HOYA Corp.)
6.13. Philips Healthcare
6.14. Proteus Digital Health, Inc.
6.15. Smart Pill Inc.
6.16. Stryker Corp